Human-level artificial intelligence (AI), popularly referred to as Artificial General Intelligence (AGI) could arrive by as ...
Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...
Demis Hassabis, a childhood chess prodigy, said his experience with the game afforded him his first brush with AI. He was ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
Demis, who was last year jointly awarded the Nobel Prize in Chemistry with Google DeepMind colleague Dr John Jumper for their ...
Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Google’s artificial intelligence arm DeepMind has been holding back the release of its world-renowned research, as it seeks ...
Sissie Hsaio, the Google exec who oversaw the launch of the company’s AI chatbot, is stepping down as head of the Gemini app, ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results